Molecular Partners AG (NASDAQ:MOLN – Get Free Report) shares were up 5.5% on Thursday . The company traded as high as $4.66 and last traded at $4.66. Approximately 2,515 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 26,157 shares. The stock had previously closed at $4.41. Analyst […]
Molecular Partners AG (OTCMKTS:MLLCF – Get Free Report) was the recipient of a significant drop in short interest in January. As of January 15th, there was short interest totalling 71,700 shares, a drop of 8.9% from the December 31st total of 78,700 shares. Based on an average trading volume of 7,900 shares, the days-to-cover ratio […]
Tetra-specific T-cell engager MP0533 for patients with r/r AML and AML/MDS on track to deliver expanded clinical phase 1/2a data in H1 2024Progress of Radio-DARPin Therapy (RDT) platform: Improved tumor to kidney uptake
Tetra-specific T-cell engager MP0533 for patients with r/r AML and AML/MDS on track to deliver expanded clinical phase 1/2a data in H1 2024Progress of.
Molecular Partners Provides Updates at 42nd Annual J P Morgan Healthcare Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.